Jafron Biomedical Co.,Ltd. (SHE:300529)
China
· Delayed Price · Currency is CNY 18.71
-0.27 (-1.42%)
At close: Mar 9, 2026
Jafron Biomedical Company Description
Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide.
The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps.
The company was founded in 1989 and is based in Zhuhai, China.
Jafron Biomedical Co.,Ltd.
| Country | China |
| Founded | 1989 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,500 |
| CEO | Fan Dong |
Contact Details
Address: No. 98 Technology Six Road Zhuhai, 519085 China | |
| Phone | 86 75 6368 9708 |
| Website | jafroninternational.com |
Stock Details
| Ticker Symbol | 300529 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002995 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Fan Dong | Chairman of Board of Directors and GM |
| Xueyun Liao | Director and Financial Director |
| De Zhi Li | Deputy General Manager |
| Xian Min Tang | Deputy GM and Director |
| Feng Li | Deputy GM and Non-Independent Director |
| Aijun Wu | Deputy General Manager |
| Rui Wang | General Manager |
| Cong Huang | Board Secretary |